[Ip-health] USTR Froman's outrageous claim

Peter Maybarduk pmaybarduk at citizen.org
Tue Feb 18 13:24:42 PST 2014

While speaking about the TPP today, Ambassador Froman outrageously claimed that the US Trade Representative's office is fostering access to affordable medicines. He highlighted a new USTR approach to the issue. 

An international coalition of health groups including MSF, Oxfam America, Fundacion Mision Salud, HealthGAP, the American Medical Student Association, Knowledge Ecology International, CEPFAR, the Student Global AIDS Campaign, the Alianza LAC-Global and Public Citizen critique that new approach and show how USTR's plans will still contribute to preventable suffering and death, in a statement available here: www.bit.ly/1jcQ8eC. 

-----Original Message-----
From: Ip-health [mailto:ip-health-bounces at lists.keionline.org] On Behalf Of Stephanie Rosenberg
Sent: Thursday, February 13, 2014 5:33 PM
To: ip-health at lists.keionline.org
Subject: [Ip-health] MSF, Oxfam, Public Citizen and others take a joint stance against USTR's "new" approach for access to medicines in TPP

USTR's proposal for the Intellectual Property Chapter of the Trans-Pacific Partnership (TPP) will endanger access to medicines for all

Over the last three years, the undersigned groups[i], public health and development experts[ii], the Vatican[iii], Members of Congress[iv], and United States trading partners[v] in the Trans-Pacific Partnership Agreement (TPP) negotiations have repeatedly expressed concerns about the public health and global access to medicines implications of the United States Trade Representative (USTR) efforts to augment pharmaceutical monopoly power by creating excessive and additional intellectual property (IP) norms in the TPP.

In response, in November 2013, during the Salt Lake City round of TPP negotiations, United States trade negotiators proposed a "differential treatment approach" to the TPP IP chapter claiming to be extending some of the public health flexibilities included in the 2007 New Trade Policy (May 10 Agreement) to the developing countries currently negotiating the TPP.[vi]

We are deeply concerned about the public health implications that these measures will have for millions of patients in need of access to affordable medicines around the whole Asia-Pacific region, and about the mischaracterization of this proposal as being coherent with the May 10 Agreement. This "new" approach not only preserves the life-threatening and access-restricting proposals that USTR has been pushing since 2011, forcing all TPP countries to go far beyond internationally agreed World Trade Organization obligations contained in the Trade-Related aspects of Intellectual Property Agreement (TRIPS), but also fails to provide adequate recognition of the urgent access to medicines needs of patients living in developing countries.


Read full statement here: bit.ly/1jcQ8eC

Ip-health mailing list
Ip-health at lists.keionline.org

More information about the Ip-health mailing list